Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.243 USD | +2.73% | +6.24% | -45.72% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 43.12 | 21.38 | 24.49 | 29.77 | - | - |
Enterprise Value (EV) 1 | 43.12 | 21.38 | 24.49 | 29.77 | 29.77 | 29.77 |
P/E ratio | -4 x | -2.16 x | -2.31 x | -3.88 x | -3.03 x | -8.57 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | 2.44 x |
EV / Revenue | - | - | - | - | - | 2.44 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -7,269,507 x | - | - | - | - | - |
FCF Yield | -0% | - | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 8,908 | 9,098 | 10,694 | 23,950 | - | - |
Reference price 2 | 4.840 | 2.350 | 2.290 | 1.243 | 1.243 | 1.243 |
Announcement Date | 3/30/22 | 3/2/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | 12.19 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -5.671 | -9.95 | -11.4 | -8.55 | -13.01 | -6.732 |
Operating Margin | - | - | - | - | - | - | -55.23% |
Earnings before Tax (EBT) 1 | - | -6.324 | -9.889 | -10.23 | -8.115 | -12.86 | -6.582 |
Net income 1 | -3.798 | -6.324 | -9.889 | -10.23 | -8.115 | -12.86 | -6.582 |
Net margin | - | - | - | - | - | - | -54% |
EPS 2 | -0.3400 | -1.210 | -1.090 | -0.9900 | -0.3200 | -0.4100 | -0.1450 |
Free Cash Flow | - | -5.931 | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 4/2/21 | 3/30/22 | 3/2/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -1.395 | -2.356 | -3.005 | -2.614 | -2.161 | -2.17 | -3.261 | -3.375 | -2.983 | -1.777 | -2.25 | -2.1 | -2.1 | -2.1 | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -1.511 | -2.355 | -3.003 | -2.594 | -2.136 | -2.156 | -3.257 | -2.327 | -1.421 | -3.227 | -2.185 | -1.96 | -1.98 | -1.99 | - |
Net income 1 | -1.511 | -2.355 | -3.003 | -2.594 | -2.136 | -2.156 | -3.257 | -2.327 | -1.421 | -3.227 | -2.185 | -1.96 | -1.98 | -1.99 | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.2700 | -0.1200 | -0.3300 | -0.2900 | -0.2400 | -0.2300 | -0.3600 | -0.2200 | -0.1300 | -0.3000 | -0.1300 | -0.0800 | -0.0700 | -0.0700 | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 3/30/22 | 5/13/22 | 8/12/22 | 11/14/22 | 3/2/23 | 5/12/23 | 8/16/23 | 11/13/23 | 4/1/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | -5.93 | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 4/2/21 | 3/30/22 | 3/2/23 | 4/1/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.72% | 29.77M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RNXT Stock
- Financials RenovoRx, Inc.